Perindopril Erbumine 4mg Tablet in PCD Pharma Franchise in Chennai

Perindopril Erbumine 4mg Tablet in Pharmaceutical Manufacturing Company in Baddi

Perindopril Erbumine 4mg Tablet in Cardiac Pharma Franchise in Pune

Perindopril Erbumine 4mg Tablet in Pharma Distributors & Suppliers in Jaipur

Perindopril Erbumine 4mg Tablet in Pharma Export Company in Ahmedabad
Perindopril Erbumine 4mg Tablet in Pharma Franchise Opportunity in Bengaluru

Home/Products /perindopril-erbumine-4-mg-tablet

About the Product

Description


Peromine 4 tablet contains Perindopril Erbumine 4 mg, an angiotensin-converting enzyme (ACE) inhibitor used primarily to manage hypertension (high blood pressure) and certain types of heart conditions. Perindopril works by inhibiting the enzyme that converts angiotensin I to angiotensin II—a powerful vasoconstrictor. By reducing angiotensin II levels, Perindopril relaxes blood vessels, lowers blood pressure, and improves blood flow, thereby reducing the workload on the heart. It also helps protect kidney function in hypertensive and diabetic patients and is widely used to manage stable coronary artery disease and chronic heart failure. The 4 mg strength is commonly used either alone or as part of a stepwise titration strategy in monotherapy or combination therapy. Perihype is recognized for its cardiovascular protective benefits, once-daily dosing, and good tolerability in long-term treatment regimens.

Common side effects of Perihype Tablet include dizziness, fatigue, headache, and a dry or persistent cough—an effect commonly associated with ACE inhibitors. Other possible adverse effects include hypotension (especially after the first dose), gastrointestinal upset, rash, and taste disturbances. In rare cases, it may cause angioedema (swelling of the face, lips, or throat), elevated potassium levels, or kidney function impairment. Periodic monitoring of blood pressure, renal function, and electrolytes is advised during therapy.

Peromine 4 tablet is indicated for the treatment of essential hypertension in adults. It is also used in the management of heart failure (especially in patients with symptomatic left ventricular dysfunction) and in reducing the risk of cardiovascular events in patients with stable coronary artery disease. It may be prescribed as monotherapy or alongside other antihypertensive agents such as diuretics or calcium channel blockers.

Peromine 4 tablet should be used only under the supervision of a qualified healthcare provider. It is not recommended during pregnancy, particularly in the second and third trimesters, due to the risk of fetal toxicity. Caution is advised in patients with kidney impairment, liver disease, or those receiving diuretics, as the risk of hypotension and electrolyte imbalance may be higher. If switching from another antihypertensive or initiating in volume-depleted patients, start under close supervision. Patients should avoid potassium-rich supplements or salt substitutes unless advised. Inform your doctor immediately if swelling, difficulty breathing, or severe dizziness occurs. Regular follow-up is essential for safe and effective use.

Store Peromine 4 tablet in a cool, dry place below 30°C. Protect it from moisture, direct sunlight, and heat. Keep the medication out of reach of children and pets. Do not use the tablet beyond its expiry date and store it in its original packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

1. What are the business opportunities for Perindopril Erbumine 4 mg Tablet in the PCD pharma franchise market?

Perindopril Erbumine 4 mg Tablet is an ACE inhibitor antihypertensive medication used for the management of hypertension (high blood pressure), chronic heart failure, and cardiovascular risk reduction in patients with heart disease. It works by relaxing blood vessels, improving blood flow, and reducing strain on the heart. This makes it a strong product in the cardiology and cardiovascular care segment, with high demand in the PCD pharma franchise market.

2. Why should medical distributors include this tablet in their range?

Medical distributors and wholesalers can benefit from consistent demand from cardiologists, physicians, and general practitioners. As hypertension and cardiac conditions require long-term therapy, Perindopril Erbumine 4 mg offers steady prescriptions, repeat purchases, and stable market growth, making it a reliable product for the cardiovascular portfolio.

3. Does Cafoli Lifecare offer PCD pharma franchise opportunities for Perindopril Erbumine 4 mg Tablet?

Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiac and antihypertensive segment with monopoly rights, quality manufacturing standards, attractive promotional support, and reliable supply chain assistance for distributors and franchise partners.

4. What benefits do wholesalers get by partnering for this ACE inhibitor tablet?

Wholesalers and distributors benefit from strong prescription demand, long-term patient adherence, growing cardiovascular disease burden, and continuous institutional requirements, making this product a profitable and sustainable addition to their pharmaceutical business when partnered with Cafoli Lifecare.

5. How can I become a distributor or franchise partner for Perindopril Erbumine 4 mg Tablet?

Medical distributors, stockists, and pharma professionals interested in cardiovascular and antihypertensive formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, promotional support, and PCD pharma franchise opportunities in the cardiac segment.